PRESIDIO PHARMACEUTICALS INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	15
#2	EPO (European Patent Office)	13
#3	Canada	12
#4	Taiwan	11
#5	Argentina	8
#6	China	7
#7	Australia	6
#8	Israel	6
#9	Peru	6
#10	Singapore	6
#11	Colombia	5
#12	Republic of Korea	5
#13	Mexico	5
#14	United States	5
#15	South Africa	5
#16	Chile	4
#17	Hong Kong	4
#18	New Zealand	4
#19	Brazil	3
#20	EAPO (Eurasian Patent Organization)	2
#21	India	1
#22	Philippines	1
#23	Ukraine	1

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Medical preparations
#4	Organic chemistry methods
#5	Peptides

Publication	Filing date	Title
WO2013163466A1	2013-04-25	Inhibitors of hepatitis c virus
MX2014009693A	2013-02-13	Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith.
WO2014055069A1	2012-10-02	Solid forms comprising an inhibitor of hcv ns5a, compositions thereof, and uses therewith
NZ609564A	2011-10-21	Inhibitors of hepatitis c virus
WO2012050918A2	2011-09-28	Tricyclic fused ring inhibitors of hepatitis c
WO2012040389A2	2011-09-21	Substituted bicyclic hcv inhibitors
EP2580209A2	2011-06-09	Inhibitors of hcv ns5a protein
EP2575475A1	2011-05-26	Inhibitors of hcv ns5a
WO2011149856A1	2011-05-23	Inhibitors of hcv ns5a
WO2010111673A1	2010-03-26	Substituted bicyclic hcv inhibitors
CN102427726A	2010-03-25	Fused ring inhibitors of hepatitis c
CA2753313A1	2010-02-22	Inhibitors of hcv ns5a
NZ713247A	2009-12-02	Inhibitors of hcv ns5a
CA2746004A1	2009-12-02	Inhibitors of hcv ns5a
WO2010065668A1	2009-12-02	Inhibitors of hcv ns5a
UA110458C2	2009-12-02	Inhibitors ns5a vgs
CA2694955A1	2006-05-15	3,4-disubstituted coumarin and quinolone compounds